한국지질동맥경화학회 학술대회

Symposium 2, titled “Cutting-edge Nutritional Approach for Cardiometabolic Risk Strategies,” will highlight the latest research in nutritional science aimed at preventing and treating cardiovascular and metabolic diseases. Professor Jordi Merino Ribas (University of Copenhagen, Denmark) will examine the interplay between molecular and environmental factors in the new era of precision medicine, laying the foundation for personalized nutritional strategies. Professor Hyun Ju You (Seoul National University, Republic of Korea) will assess the relationship between the human microbiome and cardiometabolic health. Dr. Hyekyoung Sung (York University, USA) will then present in-depth insights into the nutritional regulation of iron metabolism in cardiometabolic diseases. These distinguished presentations will feature the efficacy of personalized nutritional interventions in guiding comprehensive prevention and management strategies for cardiovascular and metabolic disorders.

The rapid advancement of artificial intelligence (AI) is transforming precision diagnostics and risk stratification in atherosclerosis and cardiovascular diseases. In this symposium, leading experts will present the most recent studies leveraging AI for accurate diagnosis and risk assessment of cardiovascular conditions. Professor Paul Leeson from University of Oxford, UK, will provide insights from the PROTEUS randomized controlled trial (RCT), demonstrating how AI-assisted stress echocardiography can enhance the diagnosis of coronary atherosclerosis and cardiovascular risk prediction. Subsequently, Dr. Junmyung Kwon from Medical AI, Republic of Korea, will discuss the application of AI-enhanced electrocardiography technology for early detection of acute myocardial infarction and effective cardiovascular risk stratification. Lastly, Professor SungA Bae from Yonsei University, Republic of Korea, will present findings from the AI-Gatekeeper RCT trial, comparing artificial intelligence-based screening of coronary artery disease with usual clinical care, showcasing its clinical advantages and potential implications. This symposium provides an excellent opportunity to explore how integrating clinical medicine with AI technology is shaping the future of precision cardiovascular medicine.

Although luminal narrowing has traditionally guided our understanding of intracranial atherosclerosis and captured clinicians’ attention, growing evidence reveals that its impact reaches well beyond narrowing alone. This session, “What Is Important beyond Stenosis in Intracranial Atherosclerosis,” explores three key dimensions-vascular tortuosity and plaque burden, vessel wall enhancement and inflammation, and blood viscosity’s role in cerebral flow and stroke risk. Professor Mi-Yeon Eun, who is a stroke neurologist and neuro-interventionist from Kyungbook National University Chilgok Hospital, Republic of Korea, will present the relation between intracranial vascular tortuosity and overall atherosclerosis burden. Professor Dong-Wan Kang, a stroke neurologist from Seoul National University Bundang Hospital, Republic of Korea, will present the clinical impact of vascular enhancement and inflammation detected from high resolution vessel wall MRI. Professor Ho Geol Woo, a stroke neurologist and neuro-interventionist from Kyung Hee University Hospital, Republic of Korea, will present how blood viscosity affect development and stability of intracranial atherosclerosis. Together, these insights push us toward a more holistic approach to diagnosis and management of intracranial atherosclerosis.